Brief: ChromoGenics Q4 EBITDA Loss Widens To SEK 14 Mln

ChromoGenics AB

08/02/2022 07:37

Feb 8 (Reuters) - ChromoGenics AB  CHRO.ST :
    * INCREASES ITS NET SALES AND COMPLETES SHARE ISSUE FOR SEK
68.2
MILLION, GUARANTEED TO 80 PERCENT
    * Q4 NET SALES SEK 13,7 MILLION VERSUS SEK 2.0 MILLION YEAR
AGO
    * Q4 EBITDA LOSS SEK 14.0 MILLION VERSUS LOSS SEK 7.6
MILLION YEAR
AGO

Source text for Eikon:  ID:nWkr2MPnnF 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))